Everlywell Launches Next-Gen AI Health Platform Eva to Power Smarter, Scalable Care

Audio By Carbonatix

AUSTIN, Texas--(BUSINESS WIRE)--Oct 2, 2025--

Everlywell, a leader in digital health, today announced the launch of Eva—an AI-powered platform that turns complex biomarker data into easy-to-understand, personalized health insights. Eva combines intelligence with engaging tools to guide and motivate individuals to take meaningful action for their health.

Eva is an intelligent health companion that helps personalize crucial touchpoints with smart recommendations and insights throughout the healthcare journey, including an AI-powered engagement model, care plans and clinician support, and CX agent:

• Eva Engage: AI-powered proactive outreach that connects people at the right time with the right care, automatically scaling personalized health engagement for enterprise partners, including health plans and employers.
• Eva Care: Smart care coordination that helps create personalized treatment pathways and connects people seamlessly with Everlywell's affiliated provider network.
• Eva Support: Comprehensive AI navigator that instantly handles product questions, technical support, account management, and customer service needs.

Designed to reshape how and where healthcare happens, Eva integrates diagnostics, virtual care, and engagement into one seamless, end-to-end experience. With billions of engagement data points, Everlywell’s platform powers predictive outreach and dynamic care plans—fueling measurable outcomes for consumers and efficiency for enterprise partners. Later this year, Everlywell will expand Eva’s capabilities to streamline clinician workflows, including clinical charting and documentation.

For enterprise partners, Eva will guide a member through their entire care journey. A member who has never measured their blood pressure before, for example, can be engaged with personalized communications from Eva Engage, guided to the right blood pressure monitoring device by Eva Care with results interpreted instantly and a tailored care plan from a clinician—all in one connected care journey with Eva.

“We defined accessible, simple lab testing over the past decade—delivering health insights to 60 million Americans—and now we’re deploying the intelligence layer that healthcare has been missing,” said Julia Cheek, Founder and CEO of Everlywell. “This is proactive, personalized care powered by AI and grounded in clinical rigor. We’re not replacing human insight. We’re using AI-powered technology to scale it.”

Already embedded across Everlywell’s care ecosystem, Eva has delivered a measurable impact in patient engagement, clinical efficiency, and care gap closure. Everlywell 360 care plans are more insightful than ever with AI-enhanced, clinician-reviewed insights, and consumer engagement rates have more than doubled with Eva Support. For enterprise partners, this will mean higher return rates, lower costs per member, and a smooth experience that keeps patients engaged in their health journey—powered by machine learning models and voice agentic AI engagement.

With non-COVID enterprise revenue growing nearly 300% since 2020, Everlywell already delivers care to nearly 100 enterprise partners from health plans to diagnostic leaders. For our partners, Eva marks what’s next: AI-powered solutions that make care more connected, more effective, and more personalized.

About Everlywell

Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. Everlywell transforms complex biomarker data into life-changing insights—seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens.

Over the past decade, Everlywell has delivered nearly 1 billion personalized health insights, transformed care for 60 million people and powered hundreds of enterprise partners, including 4 of the top 5 largest health plans in the U.S. that cover 170 million insured lives. In 2024 alone, an estimated 1 in 86 U.S. households received an Everlywell test, solidifying its spot as the #1 at-home testing brand in the country. Fueled by AI and built for scale, Everlywell is breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. Learn more at everlywell.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251002738702/en/

CONTACT: Jensen Cannon, Everlywell

[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SOFTWARE PRACTICE MANAGEMENT GENERAL HEALTH HEALTH ARTIFICIAL INTELLIGENCE DATA MANAGEMENT HEALTH TECHNOLOGY TECHNOLOGY

SOURCE: Everlywell

Copyright Business Wire 2025.

PUB: 10/02/2025 09:07 AM/DISC: 10/02/2025 09:06 AM

http://www.businesswire.com/news/home/20251002738702/en